TY  - RPRT
TI  - Comprehensive analysis suggests CRIF1 is a potential target in breast cancer associated with prognosis and immune infiltration.
AU  - Yongping Li
AU  - Jie Liu
AU  - Ming Zhong
AU  - Weiping Yu
AU  - Hongbo Zhu
AU  - Xueting Wang
AU  - Hao Yuan
PY  - 2026
DO  - 10.1080/07853890.2025.2593151
UR  - https://pubmed.ncbi.nlm.nih.gov/42116756/
ID  - 42116756
ER  -